Data as of 3:56pm ET
| +0.10 / +1.17%|
The 1 analysts offering 12-month price forecasts for Accretive Health Inc have a median target of 14.00, with a high estimate of 14.00 and a low estimate of 14.00. The median estimate represents a +61.85% increase from the last price of 8.65.
The current consensus among 1 polled investment analysts is to Buy stock in Accretive Health Inc. This rating has held steady since December, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.